drugset

drugset / Trial / NCT03404869

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

NCT03404869 ↗

Phase 1/2 Unknown 5 enrolled Orpha Labs

NaSingle-groupOpen-labelTreatment

Summary

Study of ORL-1M in Patients With CDG-Ib

Timeline

Start: 2015-03-31
Primary completion: 2019-06-01
Completion: 2019-06-01

Publications

Rebelo AL, Chevalier MT, Russo L, Pandit A. Role and therapeutic implications of protein glycosylation in neuroinflammation. Trends Mol Med. 2022 Apr;28(4):270-289. doi: 10.1016/j.molmed.2022.01.004. Epub 2022 Feb 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ORL-1M	Unknown	—	Oral

Indications